TW248557B - - Google Patents

Info

Publication number
TW248557B
TW248557B TW082106679A TW82106679A TW248557B TW 248557 B TW248557 B TW 248557B TW 082106679 A TW082106679 A TW 082106679A TW 82106679 A TW82106679 A TW 82106679A TW 248557 B TW248557 B TW 248557B
Authority
TW
Taiwan
Application number
TW082106679A
Other languages
Chinese (zh)
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929217674A external-priority patent/GB9217674D0/en
Priority claimed from GB939306461A external-priority patent/GB9306461D0/en
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Application granted granted Critical
Publication of TW248557B publication Critical patent/TW248557B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
TW082106679A 1992-08-20 1993-08-19 TW248557B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217674A GB9217674D0 (en) 1992-08-20 1992-08-20 Novel compounds
GB939306461A GB9306461D0 (en) 1993-03-29 1993-03-29 Novel compounds

Publications (1)

Publication Number Publication Date
TW248557B true TW248557B (en:Method) 1995-06-01

Family

ID=26301461

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082106679A TW248557B (en:Method) 1992-08-20 1993-08-19

Country Status (13)

Country Link
EP (1) EP0656003A1 (en:Method)
JP (1) JPH08500580A (en:Method)
CN (1) CN1086819A (en:Method)
AP (1) AP9300560A0 (en:Method)
AU (1) AU4704693A (en:Method)
CA (1) CA2142721A1 (en:Method)
IL (1) IL106737A0 (en:Method)
MA (1) MA22955A1 (en:Method)
MX (1) MX9305037A (en:Method)
NZ (1) NZ254785A (en:Method)
SI (1) SI9300438A (en:Method)
TW (1) TW248557B (en:Method)
WO (1) WO1994004533A1 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306460D0 (en) * 1993-03-29 1993-05-19 Smithkline Beecham Plc Novel compounds
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
GB9402542D0 (en) * 1994-02-10 1994-04-06 Smith Kline Beecham Plc Novel compounds
WO1995029177A1 (en) * 1994-04-23 1995-11-02 Smithkline Beecham P.L.C. Tricyclic derivatives as 5ht2c and 5ht2b antagonists
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
GB9420999D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
ES2151652T3 (es) * 1995-02-02 2001-01-01 Smithkline Beecham Plc Derivados de indol como antagonistas del receptor 5ht.
US5972937A (en) * 1995-02-02 1999-10-26 Smithkline Beecham P.L.C. Heterocyclic compounds possessing 5HT2C receptor antagonist activity
GB9517559D0 (en) * 1995-08-26 1995-10-25 Smithkline Beecham Plc Novel compounds
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9612885D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
GB9612883D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
JP2001508767A (ja) * 1996-12-02 2001-07-03 藤沢薬品工業株式会社 5―ht拮抗作用を有するインドール―ウレア誘導体
GB9724372D0 (en) 1997-11-18 1998-01-14 Smithkline Beecham Plc Novel compounds
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
FR2807754A1 (fr) * 2000-04-13 2001-10-19 Adir Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2837823B1 (fr) * 2002-03-27 2005-04-08 Servier Lab Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003290009A1 (en) * 2002-12-23 2004-07-14 Bayer Healthcare Ag Diagnostics and therapeutics for diseases assosciated with 5-hydroxytryptamine (serotonin) receptor 2b (5-hteb)
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
WO2014049153A1 (en) * 2012-09-28 2014-04-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonists of the 5-ht2b receptor for use in the prevention or treatment of spasticity
WO2022006365A2 (en) * 2020-07-02 2022-01-06 Purdue Research Foundation Tetrahydro-3h-pyrazolo quinolone and tetrahydro-3h-pyrrolo[3,2-f]quinoline-containing compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2091246A1 (en) * 1990-09-13 1992-03-14 Ian Thomson Forbes Indole ureas as 5 ht receptor antagonist

Also Published As

Publication number Publication date
SI9300438A (en) 1994-03-31
JPH08500580A (ja) 1996-01-23
IL106737A0 (en) 1994-05-30
AP9300560A0 (en) 1995-02-19
EP0656003A1 (en) 1995-06-07
CA2142721A1 (en) 1994-03-03
AU4704693A (en) 1994-03-15
MX9305037A (es) 1994-03-31
MA22955A1 (fr) 1994-04-01
WO1994004533A1 (en) 1994-03-03
CN1086819A (zh) 1994-05-18
NZ254785A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
TW279829B (en:Method)
DK0598561T3 (en:Method)
DK0613608T3 (en:Method)
TW224186B (en:Method)
TW248557B (en:Method)
DK0599160T3 (en:Method)
DK0574087T3 (en:Method)
BR9207065A (en:Method)
TW241327B (en:Method)
DK0625187T3 (en:Method)
TW243529B (en:Method)
TW226037B (en:Method)
DK0599441T3 (en:Method)
BR9202713C1 (en:Method)
GR3024345T3 (en:Method)
AU631518B2 (en:Method)
AU2098792A (en:Method)
IN186118B (en:Method)
IN185265B (en:Method)
IN178388B (en:Method)
IN177435B (en:Method)
AU633801B1 (en:Method)
AU1313092A (en:Method)
AU2281492A (en:Method)
AU2138992A (en:Method)